Tag: veterinary oncology market forecast

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Veterinary Oncology Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The veterinary oncology market size has seen rapid growth in recent years. It is anticipated to expand from $0.45 billion in 2025 to $0.5 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The growth observed in the preceding period can be linked to a rising occurrence of cancer in companion animals, increasing recognition of veterinary oncology services, advancements in technology for surgical and radiology equipment, the expansion of veterinary hospitals and specialty clinics, and the adoption of conventional chemotherapy treatments.

The veterinary oncology market is poised for significant expansion in the upcoming years. Its valuation is projected to reach $0.77 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This projected growth is driven by several factors, including an escalating demand for personalized and targeted therapies, the wider adoption of advanced radiology and imaging techniques, the increasing application of immunotherapy and supportive care, ongoing developments in minimally invasive surgical procedures, and the integration of combined chemotherapy and targeted therapy protocols. Key trends during this period will involve the ongoing expansion of personalized and targeted veterinary cancer treatments, further advancements in minimally invasive surgical techniques, the greater embrace of sophisticated radiology and imaging technologies, the evolution of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into comprehensive treatment plans.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=9533&type=smp&name=Veterinary%20Oncology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Oncology Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of cancer in companion animals is anticipated to drive growth in the veterinary oncology market. Cancer is characterized by uncontrolled cell growth spreading within the body, with pet cancer manifesting as physical tumors like swelling. Veterinary oncology specializes in diagnosing and treating cancer in animals, aiming to limit metastasis and disease progression. Consequently, a rise in pet cancer cases will elevate the demand for veterinary oncology services. For example, The Cancer Letter, a US-based publication on cancer research, reported an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Additionally, the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, indicated in November 2023 that approximately 1 in 4 dogs and 1 in 5 cats are expected to develop cancer during their lives. Thus, the rising incidence of cancer in pets is fueling the veterinary oncology market.

Veterinary Oncology Market Segments: Where Is Growth Concentrated?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Veterinary Oncology Market Trends Powering Strategic Industry Growth

Leading companies within the veterinary oncology market are prioritizing the development of neoantigens, which are specific tumor antigens resulting from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific genetic changes within malignant cells. Unlike regular antigens found in healthy tissues, neoantigens are created as a direct consequence of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their potential in developing cancer vaccines and other immunotherapies, with the objective of specifically enhancing the immune response against cancer cells while preserving normal cells.

Veterinary Oncology Market Leading Players And Competitive Positioning

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

View The Full Veterinary Oncology Market Report:

https://thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Oncology Market Regional Split: Which Areas Are Fueling Growth?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Veterinary Oncology Market Expansion Outlook: What Revenue Opportunities Are Ahead?#_x000D_

The veterinary oncology market size has seen rapid growth in recent years. It is anticipated to expand from $0.45 billion in 2025 to $0.5 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The growth observed in the preceding period can be linked to a rising occurrence of cancer in companion animals, increasing recognition of veterinary oncology services, advancements in technology for surgical and radiology equipment, the expansion of veterinary hospitals and specialty clinics, and the adoption of conventional chemotherapy treatments._x000D_

_x000D_

The veterinary oncology market is poised for significant expansion in the upcoming years. Its valuation is projected to reach $0.77 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This projected growth is driven by several factors, including an escalating demand for personalized and targeted therapies, the wider adoption of advanced radiology and imaging techniques, the increasing application of immunotherapy and supportive care, ongoing developments in minimally invasive surgical procedures, and the integration of combined chemotherapy and targeted therapy protocols. Key trends during this period will involve the ongoing expansion of personalized and targeted veterinary cancer treatments, further advancements in minimally invasive surgical techniques, the greater embrace of sophisticated radiology and imaging technologies, the evolution of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into comprehensive treatment plans._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=9533&type=smp&name=Veterinary%20Oncology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Oncology Market Demand Drivers Opening New Revenue Streams#_x000D_

The increasing occurrence of cancer in companion animals is anticipated to drive growth in the veterinary oncology market. Cancer is characterized by uncontrolled cell growth spreading within the body, with pet cancer manifesting as physical tumors like swelling. Veterinary oncology specializes in diagnosing and treating cancer in animals, aiming to limit metastasis and disease progression. Consequently, a rise in pet cancer cases will elevate the demand for veterinary oncology services. For example, The Cancer Letter, a US-based publication on cancer research, reported an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Additionally, the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, indicated in November 2023 that approximately 1 in 4 dogs and 1 in 5 cats are expected to develop cancer during their lives. Thus, the rising incidence of cancer in pets is fueling the veterinary oncology market._x000D_

_x000D_

#Veterinary Oncology Market Segments: Where Is Growth Concentrated?#_x000D_

The veterinary oncology market covered in this report is segmented – _x000D_

_x000D_

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies _x000D_

2) By Animal Type: Equine, Canine, Feline, Other Animal Types_x000D_

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types_x000D_

_x000D_

Subsegments:_x000D_

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation_x000D_

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques_x000D_

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents_x000D_

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies_x000D_

_x000D_

#Veterinary Oncology Market Trends Powering Strategic Industry Growth#_x000D_

Leading companies within the veterinary oncology market are prioritizing the development of neoantigens, which are specific tumor antigens resulting from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific genetic changes within malignant cells. Unlike regular antigens found in healthy tissues, neoantigens are created as a direct consequence of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their potential in developing cancer vaccines and other immunotherapies, with the objective of specifically enhancing the immune response against cancer cells while preserving normal cells._x000D_

_x000D_

#Veterinary Oncology Market Leading Players And Competitive Positioning#_x000D_

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc. _x000D_

_x000D_

#View The Full Veterinary Oncology Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Oncology Market Regional Split: Which Areas Are Fueling Growth?#_x000D_

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Veterinary Oncology Market By 2030 Based On Its 2026 Value?

The veterinary oncology market has experienced significant expansion recently. Projections indicate it will expand from $0.45 billion in 2025 to reach $0.5 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.0%. Historically, this growth can be ascribed to several factors, including an increased occurrence of cancer in pets, heightened understanding of available veterinary oncology services, innovations in surgical and radiology technologies, the proliferation of veterinary hospitals and specialized clinics, and the wider acceptance of traditional chemotherapy approaches.

The veterinary oncology market is anticipated to experience significant expansion in the coming years. Its value is set to reach $0.77 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.3%. This projected growth during the forecast period stems from factors such as a heightened demand for personalized and targeted treatments, an increase in the adoption of advanced radiology and imaging, a surge in the application of immunotherapy and supportive care, advancements in minimally invasive surgical techniques, and the incorporation of combination chemotherapy and targeted therapy protocols. Key trends expected during this period involve the expansion of targeted and personalized veterinary cancer treatments, an uptake in minimally invasive surgical methods, broader implementation of advanced radiology and imaging technologies, the formulation of combination chemotherapy protocols, and the inclusion of immunotherapy and supportive care within treatment strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Important Drivers Are Powering The Veterinary Oncology Market Growth?

The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body’s cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused on cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology. For instance, according to the The Cancer Letter, a US-based publication that covers cancer research stated that in 2024, an estimated 6 million pet dogs will be diagnosed with cancer in the United States. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, November 2023, it’s estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer in their lifetime. Therefore, the growing prevalence of cancer in pets is driving the veterinary oncology market.

What Key Segment Areas Are Included In The Veterinary Oncology Market Assessment?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Which Trends Are Affecting The Veterinary Oncology Market Framework?

Major companies operating in the veterinary oncology market are focused on developing neoantigens, which are unique tumor-specific antigens that arise from mutations in cancer cells. Neoantigens are unique protein fragments that arise from tumor-specific mutations in cancer cells. Unlike normal antigens found in healthy tissues, neoantigens are produced as a result of genetic changes (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company launched cancer vaccine trial for dogs. Neoantigens are being explored in the development of cancer vaccines and other immunotherapies, with the goal of enhancing the immune response specifically against cancer cells while sparing normal cells.

Which Firms Are Competing In The Veterinary Oncology Market?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Which Regional Market Leads The Veterinary Oncology Market?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Veterinary Oncology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Autoimmune Hemolytic Anemia Treatment Market By The End Of 2030?

The veterinary oncology market has witnessed rapid expansion in recent years. Its size is projected to increase from $0.45 billion in 2025 to $0.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.0%. This historical growth can be linked to several factors, including a higher incidence of cancer among companion animals, increasing recognition of veterinary oncology provisions, technological progress in surgical and radiology equipment, the expansion of veterinary hospitals and specialized clinics, and the embrace of traditional chemotherapy treatments.

The veterinary oncology market size is set to experience substantial growth in the forthcoming years. It is forecast to grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. This expansion during the projection period is primarily due to a rising demand for customized and specific treatments, increased adoption of advanced radiology and imaging, a surge in the use of immunotherapy and supportive care, the evolution of less invasive surgical techniques, and the integration of combination chemotherapy with targeted therapy protocols. Significant patterns expected in this forecast period include the broadening of targeted and personalized veterinary cancer therapies, an increase in minimally invasive surgical methods, greater uptake of advanced radiology and imaging technologies, the development of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into treatment plans.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Primary Drivers Are Shaping The Development Of The Autoimmune Hemolytic Anemia Treatment Market?

The increasing incidence of cancer in companion animals is anticipated to drive the veterinary oncology market forward. Cancer is a condition where certain cells in the body grow uncontrollably and spread to other areas. In pets, cancer is recognized by the physical manifestations of a tumor, such as swelling. Veterinary oncology specializes in the diagnosis and treatment of cancer in animals, with the goal of reducing metastasis and the spread of the disease. Consequently, a rise in pet cancer cases will boost the demand for veterinary oncology. For instance, The Cancer Letter, a US-based publication covering cancer research, reported that an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, in November 2023, it was estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer during their lifetime. Therefore, the growing prevalence of cancer in pets is a key driver for the veterinary oncology market.

Which Segment Classifications Shape The Autoimmune Hemolytic Anemia Treatment Market?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

How Are Trends Impacting The Veterinary Oncology Market?

Leading companies in the veterinary oncology market are focusing on the development of neoantigens, which are distinct tumor-specific antigens that stem from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific mutations within cancer cells. In contrast to normal antigens found in healthy tissues, neoantigens are produced as a direct result of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their role in developing cancer vaccines and other immunotherapies, with the aim of specifically amplifying the immune response against cancer cells while preserving normal cells.

Which Companies Are Expanding Their Footprint In The Autoimmune Hemolytic Anemia Treatment Market?

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

Read the full veterinary oncology market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

How Does The Autoimmune Hemolytic Anemia Treatment Market Perform Across Major Global Regions?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Hemolytic Anemia Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Browse Through More Reports Similar to the Global Veterinary Oncology Market 2026, By The Business Research Company

Wheat Protein Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wheat-protein-global-market-report

Clinical Nutritions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Medical Foods Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Autoimmune Hemolytic Anemia Treatment Market By The End Of 2030?

The veterinary oncology market has witnessed rapid expansion in recent years. Its size is projected to increase from $0.45 billion in 2025 to $0.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.0%. This historical growth can be linked to several factors, including a higher incidence of cancer among companion animals, increasing recognition of veterinary oncology provisions, technological progress in surgical and radiology equipment, the expansion of veterinary hospitals and specialized clinics, and the embrace of traditional chemotherapy treatments.

The veterinary oncology market size is set to experience substantial growth in the forthcoming years. It is forecast to grow to $0.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. This expansion during the projection period is primarily due to a rising demand for customized and specific treatments, increased adoption of advanced radiology and imaging, a surge in the use of immunotherapy and supportive care, the evolution of less invasive surgical techniques, and the integration of combination chemotherapy with targeted therapy protocols. Significant patterns expected in this forecast period include the broadening of targeted and personalized veterinary cancer therapies, an increase in minimally invasive surgical methods, greater uptake of advanced radiology and imaging technologies, the development of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into treatment plans.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Primary Drivers Are Shaping The Development Of The Autoimmune Hemolytic Anemia Treatment Market?

The increasing incidence of cancer in companion animals is anticipated to drive the veterinary oncology market forward. Cancer is a condition where certain cells in the body grow uncontrollably and spread to other areas. In pets, cancer is recognized by the physical manifestations of a tumor, such as swelling. Veterinary oncology specializes in the diagnosis and treatment of cancer in animals, with the goal of reducing metastasis and the spread of the disease. Consequently, a rise in pet cancer cases will boost the demand for veterinary oncology. For instance, The Cancer Letter, a US-based publication covering cancer research, reported that an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, in November 2023, it was estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer during their lifetime. Therefore, the growing prevalence of cancer in pets is a key driver for the veterinary oncology market.

Which Segment Classifications Shape The Autoimmune Hemolytic Anemia Treatment Market?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

How Are Trends Impacting The Veterinary Oncology Market?

Leading companies in the veterinary oncology market are focusing on the development of neoantigens, which are distinct tumor-specific antigens that stem from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific mutations within cancer cells. In contrast to normal antigens found in healthy tissues, neoantigens are produced as a direct result of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their role in developing cancer vaccines and other immunotherapies, with the aim of specifically amplifying the immune response against cancer cells while preserving normal cells.

Which Companies Are Expanding Their Footprint In The Autoimmune Hemolytic Anemia Treatment Market?

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

Read the full veterinary oncology market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

How Does The Autoimmune Hemolytic Anemia Treatment Market Perform Across Major Global Regions?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Hemolytic Anemia Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Browse Through More Reports Similar to the Global Veterinary Oncology Market 2026, By The Business Research Company

Wheat Protein Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wheat-protein-global-market-report

Clinical Nutritions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Medical Foods Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the insulated shippers market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Veterinary Oncology Market size between 2026 and 2035?

The veterinary oncology market size has experienced rapid expansion recently. This market is projected to expand from $0.45 billion in 2025 to $0.5 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.0%. Historically, this growth can be ascribed to several factors, including a rising incidence of cancer in companion animals, increasing awareness of veterinary oncology services, technological advancements in surgical and radiology equipment, the expansion of veterinary hospitals and specialty clinics, and the adoption of conventional chemotherapy treatments.

The veterinary oncology market is projected to experience significant expansion over the coming years, reaching $0.77 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.3%. This anticipated growth is largely attributable to an increasing demand for personalized and targeted therapies, greater adoption of advanced radiology and imaging, the rising use of immunotherapy and supportive care, the development of minimally invasive surgical techniques, and the integration of combination chemotherapy and targeted therapy protocols. During this forecast period, major trends will include the expansion of targeted and personalized veterinary cancer therapies, an increase in minimally invasive surgical techniques, growing adoption of advanced radiology and imaging technologies, the development of combination chemotherapy protocols, and the integration of immunotherapy and supportive care into treatment plans.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Which Drivers Are Impacting Market Performance In The Veterinary Oncology Market?

The rising incidence of cancer among pets is anticipated to drive the veterinary oncology market in the coming years. Cancer is characterized by the uncontrolled proliferation of certain cells within the body, which can then spread to other regions. For pets, cancer manifests physically as tumors, often appearing as swelling. Veterinary oncology specializes in the diagnosis and treatment of cancer in animals, aiming to reduce metastasis and prevent the disease from spreading. Consequently, an uptick in pet cancer cases will increase the demand for veterinary oncology services. For example, The Cancer Letter, a US-based publication dedicated to cancer research, reported that approximately 6 million pet dogs in the United States are projected to be diagnosed with cancer in 2024. Furthermore, the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, estimated in November 2023 that during their lifetime, 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer. Thus, the rising incidence of cancer in pets is indeed driving growth in the veterinary oncology market.

Which Segments Are Contributing To The Growth Of The Veterinary Oncology Market?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Which Trends Are Shaping Activity Within The Veterinary Oncology Market?

Leading companies active in the veterinary oncology market are concentrating on developing neoantigens, which are distinct tumor-specific antigens that emerge from mutations within cancer cells. These neoantigens represent unique protein fragments that arise from tumor-specific genetic changes in cancer cells. Unlike standard antigens found in healthy tissues, neoantigens are produced as a result of genetic modifications (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, commenced a cancer vaccine trial for dogs. Neoantigens are being explored for their application in developing cancer vaccines and other immunotherapies, with the objective of enhancing the immune response specifically against cancer cells while protecting normal cells.

Who Are The Prominent Global Companies Shaping The Veterinary Oncology Market Landscape?

Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Veterinary Oncology Market?

Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Oncology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Browse Through More Reports Similar to the Global Veterinary Oncology Market 2026, By The Business Research Company

Wheat Protein Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/wheat-protein-global-market-report

Clinical Nutritions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Medical Foods Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Veterinary Oncology Market Size Shifted, And What Is the Outlook Through 2034?

In the last few years, the veterinary oncology market has experienced swift expansion. The market, which stood at $0.4 billion in 2024, is projected to enlarge to $0.45 billion in 2025, with a compound annual growth rate (CAGR) of 12.3%. The historic period’s escalation can be linked to factors such as a jump in pet ownership, the treatment of pets as family members, application of knowledge from human oncology, heightened consciousness about pet health, and advancements in veterinary drugs.

How Much Will the Veterinary Oncology Market Be Worth in 2029?

The market for veterinary oncology is anticipated to experience swift expansion in the coming years, reaching a value of $0.69 billion in 2029, driven by a compound annual growth rate (CAGR) of 11.0%. This projected increase during the forecasting period could be due to factors such as the adoption of personalized treatments for animals, increasing instances of cancer in animals, a growing elderly pet demographic, more available specialized care, and regulatory support and approval. Significant trends during this forecast period include the progression of diagnostic technologies, personalized treatment methods, advancements in immunotherapy, targeted treatments, and the use of telemedicine for oncology consultations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Which is the Largest Company in the Veterinary Oncology Market?

Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

What Are the Main Market Drivers in the Veterinary Oncology Industry?

The rising incidence of cancer among household animals is anticipated to boost the growth of the veterinary oncology market. The anomaly of cancer arises when certain body cells multiply uncontrollably and invade other parts of the body. When it comes to pets, cancer refers to the visible signs such as tumors and swellings. Veterinary oncology primarily deals with the detection and treatment of cancer in animals, aiming to limit disease diffusion and metastasis. Consequently, an upswing in the rates of pet cancer will amplify the demand for veterinary oncology. For example, The Cancer Letter, a U.S. news publication focusing on cancer research, projected that about 6 million pet dogs in the U.S will be diagnosed with cancer in 2024. Moreover, the British Small Animal Veterinary Association (BSAVA), a UK-based animal health organization, estimated in November 2023, that 1 in 4 dogs and 1 in 5 cats would get a cancer diagnosis in their lifespan. Therefore, the escalating occurrence of cancer in pets is fueling the expansion of the veterinary oncology market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

How Is the Veterinary Oncology Market Segments Structured?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

What Strategic Trends Are Transforming the Veterinary Oncology Market?

Leading businesses in the veterinary oncology market are concentrating on the progress of neoantigens, which are distinct antigens occurring from mutations in cancer cells and are unique to the tumor. Unlike antigens found in non-diseased tissues, these neoantigens result from genetic alterations within the DNA of the tumor. For instance, in October 2024, Biotechnology company, a firm based in the US initiated a cancer vaccine trial for dogs. The utilization of neoantigens in the crafting of cancer vaccines and other types of immunotherapy is under exploration, with the intent of amplifying the immune response to combat cancer cells specifically, while leaving normal cells untouched.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Which Global Regions Offer the Highest Growth in the Veterinary Oncology Market?

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

This Report Delivers Insight On:

1. How big is the veterinary oncology market, and how is it changing globally?

2. Who are the major companies in the veterinary oncology market, and how are they performing?

3. What are the key opportunities and risks in the veterinary oncology market right now?

4. Which products or customer segments are growing the most in the veterinary oncology market?

5. What factors are helping or slowing down the growth of the veterinary oncology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the veterinary oncology industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Veterinary Oncology Market Growth Performance Trended Historically, And What Lies Ahead?

In recent years, the market size of veterinary oncology has experienced significant growth. It is projected to expand from $0.4 billion in 2024 to $0.45 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.3%. The growth that occurred in the historic period is largely due to factors such as a rise in pet ownership, the humanization of pets, the transfer of knowledge from human oncology, growing cognizance of pet health, and advancements in pharmaceuticals.

In the upcoming years, the market size of veterinary oncology is projected to experience swift expansion. It is anticipated to leap to $0.69 billion by 2029, with a compound annual growth rate (CAGR) of 11.0%. Factors such as the rise in personalized animal medication, an increase in cancer prevalence among animals, an ageing pet population, improved access to specialist care, along with regulatory support and authorizations, contribute to the anticipated growth during the forecast period. Leading trends during this forecast period encompass innovative diagnostic technologies, personalized treatment strategies, progress in immunotherapy, targeted therapies, and the use of telemedicine in oncology discussions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Veterinary Oncology Market?

The increased incidence of cancer among pets is anticipated to fuel the growth of the veterinary oncology market. Cancer, a disease marked by unchecked cell proliferation that subsequently spreads to other parts of the body, has similar physical symptoms in pets, including tumors and swelling. Veterinary oncology, therefore, aims to diagnose and treat these cancers in animals, aiming to curtail disease spread and metastasis. Thus, a rise in cancer cases among pets creates a high demand for veterinary oncology. As per The Cancer Letter, a publication based in the US that specializes in cancer research, approximately 6 million pet dogs in the US will contract cancer by 2024. In addition, the British Small Animal Veterinary Association (BSAVA), a veterinary group from the UK, estimated in November 2023 that 1 in 4 dogs and 1 in 5 cats are likely to receive a cancer diagnosis in their lifetime. Consequently, this mounting pet cancer incidence is propelling the veterinary oncology market forward.

Which Primary Segments of the Veterinary Oncology Market Are Driving Growth and Industry Transformations?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Which Regions Are Key Players in the Growth of the Veterinary Oncology Market?

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Are the Most Significant Market Trends in the Veterinary Oncology Market?

Leading entities in the veterinary oncology market are channeling their efforts towards the creation of neoantigens, exclusively tumor-specific antigens stemming from mutations in cancer-ridden cells. Unlike standard antigens present in healthy tissues, these neoantigens arise as a consequence of genetic alterations in the tumor’s DNA. An example of this can be seen in Biotechnology company, a US-based firm that embarked on a cancer vaccine trial for dogs in October 2024. The ambition behind developing neoantigens lies within the concept of cancer vaccines, along with other potential immunotherapies, with the objective to amplify immune reactions specifically against cancerous cells and simultaneously preserve regular cells.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

What Parameters Are Used to Define the Veterinary Oncology Market?

Veterinary oncology refers to the diagnosis and treatment of cancer by specially trained experts to integrate cancer treatment with underlying conditions while sustaining a quality of life in animals. It deals with cancer medicine and treatment services in animals.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Veterinary Oncology Market?

The veterinary oncology market is expected to grow due to the rising prevalence of cancer in pets. With an increasing number of pet dogs and cats being diagnosed with cancer, the demand for veterinary oncology services is on the rise. In 2024, an estimated 6 million pet dogs in the US will be diagnosed with cancer, further driving this market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

#What is the Growth Potential of the Veterinary Oncology Market, and How Will It Perform by 2034?

The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.4 billion in 2024 to $0.45 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. This growth is attributed to increasing pet ownership, the humanization of pets, knowledge transfer from human oncology, growing awareness of pet health, and advancements in pharmaceutical treatments for animals.

The veterinary oncology market is set to grow rapidly to $0.69 billion by 2029, at a CAGR of 11.0%. Growth is driven by personalized medicine for animals, the rising prevalence of cancer in pets, the growing geriatric pet population, better access to specialized care, and regulatory support and approvals. Key trends include advanced diagnostic technologies, personalized treatments, advancements in immunotherapy and targeted therapies, and the rise of telemedicine for oncology consultations.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

What Are the Latest Innovations Influencing theVeterinary Oncology Market?

Companies in the veterinary oncology market are focusing on neoantigens, unique tumor-specific proteins generated by mutations in cancer cells. These neoantigens are central to developing cancer vaccines and immunotherapies aimed at targeting cancer cells without affecting healthy tissues. In October 2024, a US-based biotechnology company launched a cancer vaccine trial for dogs, exploring the potential of neoantigens in veterinary oncology.

What Are the Top Market Players Propelling the Growth of theVeterinary Oncology Industry?

Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Which Primary Segments of the Veterinary Oncology Market Are Driving Growth and Industry Transformations?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Veterinary Oncology Market?# Market?

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Browse Through More Reports Similar to the Global Veterinary Oncology Market 2025, By The Business Research Company:

Nutritional Feed Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Sports Nutrition Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sports-nutrition-global-market-report

Functional Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/functional-foods-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the veterinary oncology market?

In the recent past, the veterinary oncology market has expanded at a speedy pace. This market, which stood at $0.4 billion in 2024, is expected to rise to $0.45 billion in 2025, representing a compound annual growth rate (CAGR) of 12.3%. The advancement in the past years was driven by factors such as higher pet ownership rates, the trend of treating pets like family members, the application of knowledge from human oncology to animal cancer treatment, growing cognizance about pet health, and progress in the pharmaceutical sector.

What will be the veterinary oncology market size in the future?

In the upcoming years, the veterinary oncology market is predicted to experience a significant expansion. With a compound annual growth rate (CAGR) of 11.0%, the market size is projected to reach $0.69 billion by 2029. Factors contributing to this sizeable growth during the forecast period include the popularity of personalized medication for animals, an increase in cancer cases among animals, a growing older pet population, broader access to specialized animal healthcare services, and regulatory support and approval. The forecast period also expects to see significant trends including state-of-the-art diagnostic methods, customized treatment protocols, advancements in immunotherapy, targeted treatments, and the use of telemedicine for oncology consultations.

Get your veterinary oncology market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

What main drivers are fueling expansion in the veterinary oncology market?

The veterinary oncology market is projected to grow due to the increasing rates of cancer among pets. Cancer involves a malfunction in the body’s cells which leads to uncontrollable growth and spread to other parts of the body. When it comes to pets, these sequences often manifest as physical signs such as tumors. Veterinary oncology aims to diagnose and treat cancer in animals, primarily by minimizing the spread of the disease and its metastasis. Consequently, the surge in pet cancer directly amplifies the demand for veterinary oncology. For example, The Cancer Letter, a U.S. publication dedicated to cancer research, predicts that around 6 million pet dogs will be affected by cancer in the U.S. by 2024. In addition, the British Small Animal Veterinary Association (BSAVA), a U.K.-based veterinary group, foresees that about one-fourth of dogs and one-fifth of cats will be diagnosed with cancer in their lifetime, as per their November 2023 estimation. This growing incidence of cancer in pets is thus fueling the expansion of the veterinary oncology market.

What key areas define the segmentation of the global veterinary oncology market?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Who are the dominant players expanding their reach in the veterinary oncology market?

Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

How are evolving market trends shaping veterinary oncology Strategies?

Leading businesses in the veterinary oncology market are prioritizing the production of neoantigens, distinctive tumor-specific antigens generated by cancer cell mutations. These neoantigens, essentially unique protein fragments, are the products of tumor-specific alterations in cancer cells. Different from their normal counterparts present in healthy tissues, these neoantigens are generated due to genetic variations within the tumor’s DNA. As an example, in October 2024, a US biotech company initiated a cancer vaccine trial for canines. The exploration of neoantigens is ongoing, in the quest to improve cancer vaccines and other immunotherapy approaches, with a focused objective of boosting the immune response particularly against cancer cells, without negatively affecting normal cells.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

Which regions are emerging as leaders in the veterinary oncology market?

Asia-Pacific was the largest region in the veterinary oncology market in 2024. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Nutritional Feed Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Sports Nutrition Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sports-nutrition-global-market-report

Functional Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/functional-foods-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: